234 related articles for article (PubMed ID: 25864459)
1. Survival outcomes in patients with multiple primary melanomas.
Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.
Youlden DR; Khosrotehrani K; Green AC; Soyer HP; Kimlin MG; Youl PH; Aitken JF; Baade PD
Australas J Dermatol; 2016 Feb; 57(1):57-60. PubMed ID: 26776229
[TBL] [Abstract][Full Text] [Related]
3. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
4. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
5. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
7. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
8. Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).
Grossman D; Farnham JM; Hyngstrom J; Klapperich ME; Secrest AM; Empey S; Bowen GM; Wada D; Andtbacka RHI; Grossmann K; Bowles TL; Cannon-Albright LA
J Am Acad Dermatol; 2018 Aug; 79(2):238-244. PubMed ID: 29499295
[TBL] [Abstract][Full Text] [Related]
9. Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.
Jones MS; Torisu-Itakura H; Flaherty DC; Schoellhammer HF; Lee J; Sim MS; Faries MB
Am Surg; 2016 Oct; 82(10):1009-1013. PubMed ID: 27779995
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.
Joosse A; van der Ploeg AP; Haydu LE; Nijsten TE; de Vries E; Scolyer RA; Eggermont AM; Coebergh JW; Thompson JF
Ann Surg Oncol; 2015 May; 22(5):1598-603. PubMed ID: 25408275
[TBL] [Abstract][Full Text] [Related]
11. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
13. Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
Youlden DR; Baade PD; Soyer HP; Youl PH; Kimlin MG; Aitken JF; Green AC; Khosrotehrani K
J Invest Dermatol; 2016 Nov; 136(11):2270-2276. PubMed ID: 27019458
[TBL] [Abstract][Full Text] [Related]
14. Melanoma survival is superior in females across all tumour stages but is influenced by age.
Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
[TBL] [Abstract][Full Text] [Related]
15. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
16. Melanoma survival disadvantage in young, non-Hispanic white males compared with females.
Gamba CS; Clarke CA; Keegan TH; Tao L; Swetter SM
JAMA Dermatol; 2013 Aug; 149(8):912-20. PubMed ID: 23804160
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of a second invasive primary melanoma according to tumour stage.
Youlden DR; Baade PD; Aitken JF; Green AC; Khosrotehrani K
Br J Dermatol; 2017 Dec; 177(6):e336-e337. PubMed ID: 28771669
[No Abstract] [Full Text] [Related]
18. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
19. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
20. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
